Tag: Tasmania Gender Service
-
Why an Inquiry into Tasmania Gender Service Is Essential
Women Speak Tasmania recently wrote to Health Minister Guy Barnett, drawing attention to serious concerns about the Tasmanian Gender Service (TGS), its practices, and the lack of transparency—and advocating for an urgent inquiry. Here’s a breakdown of our key points and the minister’s response, which signals a significant step forward. Key Concerns Raised by WST…
-
Banned Drug Leuprorelin Acetate still being Prescribed in Tasmania.
The drug leuprorelin acetate, now banned in the UK from use as a puberty blocker, is still being prescribed by the Tasmanian Gender Service (TGS). Sweden, Finland, Norway, and Italy have also implemented bans on the use of puberty blockers for under 18’s because of risks to patient safety. The bans have been implemented following…
-
Puberty Blockers Given Off Label at Tasmanian Gender Service
Information obtained under Right to Information on the Tasmanian Gender Service (TGS) confirms the need for the Health Minister Guy Barnett to conduct an urgent Inquiry into the TGS: standards of care, transparency of the agency and use of off label Puberty Blockers. Women Speak Tasmania have forwarded the RTI documents to Guy Barnett as…
-
Inquiry into The Tasmanian Gender Service – Letters to Tasmania Health Minister Guy Barnett
WST members campaigned for the safeguarding of children and the banning of Puberty blockers in children. We also request a proper inquiry into Tasmania Gender clinics Letter from Dr Elizabeth Caballero 05.05.2024 Dear Health Minister Guy Barnett, I am writing in regards to the RTI Documents and Cass Report on Australian gender clinics that confirm…
-
Leuprorelin Acetate: The Puberty Blocker Used in Tasmanian Gender Service
Through a recent Right to Information (RTI) request, Women Speak Tasmania confirmed that the only puberty blocker prescribed by the Tasmanian Gender Service (TGS) for minors is Leuprorelin acetate 30mg. This drug is given to children and adolescents diagnosed with gender dysphoria to halt the natural progression of puberty. What is Leuprorelin Acetate? Leuprorelin acetate…
-
Tasmanian Gender Service: What we learned from our RTI request
At Women Speak Tasmania, we believe transparency is essential when it comes to healthcare services that impact children and young people. That’s why we lodged a Right to Information (RTI) request to the Department of Health seeking detailed data about the Tasmanian Gender Service (TGS). The RTI has now been decided, and here’s what we…
-
Candidates Back Inquiries into Tasmanian Gender Service and Sex Self ID laws
Women Speak Tasmania are pleased to announce that in response to a questionnaire (see below) sent to all candidates the following 16 Independent and Shooters, Fishers, and Farmers Party of Tasmania (SFFPT) candidates have backed the urgent establishment of Parliamentary Inquiries into the Tasmanian Gender Service and Sex Self ID Laws: Ind Louise Elliot, Phillip…
-
NSW Westmead Children’s Hospital Study points to urgent review of Tasmanian Gender Service Guidelines
Premier Jeremy Rockcliff needs to take urgent action on the findings of a study covered in The Australian today including on the front page Doctor scrutiny on gender clinic reveals legal, safety fears. The Tasmanian Gender Service has come under pressure from numerous groups in Tasmania in past years over its ‘affirmative only approach’, the…
-
Who Speaks for Children? Commissioner Called to Support Gender Service Inquiry
In August 2022, Women Speak Tasmania wrote to Leanne McLean, Tasmania’s Commissioner for Children and Young People, calling for an independent inquiry into the treatment model being used by the Tasmanian Gender Service. This request followed the high-profile closure of England’s Tavistock Gender Identity Development Service, after an ongoing review by Dr Hillary Cass found the…